Produkty 51005-44-8

CAS 51005-44-8 występuje w naszej ofercie pod nazwami: Minecoside, Minecoside, 99.86%, Minecoside, 98%, Minecoside, >=85% (LC/MS-ELSD). Oferty producentów: Biosynth, MedChemExpress, Chemat, Sigma-Aldrich. Dostępne opakowania: 1mg, 5mg, 10mg, 1 mg, 5 mg, 10 mg, 25mg.

Minecoside
Biosynth
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 3
Zobacz produkt
Minecoside, 99.86%
MedChemExpress
  • opakowanie: 1 mg, 5 mg, 10 mg
  • Warianty: 3
od 983,78
Zobacz produkt
Minecoside, 98%
Chemat
  • opakowanie: 1mg, 5mg, 25mg
  • Warianty: 3
od 630,80
Zobacz produkt
Minecoside, >=85% (LC/MS-ELSD)
Sigma-Aldrich
  • opakowanie: 1MG
  • Warianty: 1
od 2283,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate (CAS 51005-44-8) to związek chemiczny o wzorze sumarycznym C25H30O13 i masie molowej 538.5 g/mol. Nazwa systematyczna IUPAC: [(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate. InChIKey: LRHHPZILMPIMIY-GGKKSNITSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H30O13
Masa molowa538.5 g/mol
Nazwa IUPAC[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate
InChIKeyLRHHPZILMPIMIY-GGKKSNITSA-N
SMILESCOC1=C(C=C(C=C1)/C=C/C(=O)O[C@H]2[C@@H]3C=CO[C@H]([C@@H]3[C@@]4([C@H]2O4)CO)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Minecoside, MEGxp0_001246, orb1682096, ACon1_001327, Minecoside, >=85% (LC/MS-ELSD)
Izomery (ten sam wzór sumaryczny)
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-10-yl]oxy]oxan-2-yl]methyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate C25H30O13
methyl (1S,3S,7S,12R,15R,16S,17S,18R,20E)-12-(3,4-dihydroxyphenyl)-20-ethylidene-16,17,18-trihydroxy-9-oxo-2,4,10,13,19-pentaoxatricyclo[13.3.1.13,7]icos-5-ene-6-carboxylate C25H30O13
(2S,3R,4S)-4-[2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxyethyl]-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid C25H30O13
[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate C25H30O13
(1S,3S,4S,5R,6R,7R)-1-[(4S,5R)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,6,7-trihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid C25H30O13